52 related articles for article (PubMed ID: 423420)
1. [Effect of propranolol on the ability of the liver to metabolize drugs in patients with hypertension].
Adamska-Dyniewska H; Gajewska B
Kardiol Pol; 1979; 22(1):7-11. PubMed ID: 423420
[No Abstract] [Full Text] [Related]
2. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
Traeger A; Horváth T; Rechenbach C; Jávor T
Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.
Branch RA; James JA; Read AE
Gut; 1974 Oct; 15(10):837-8. PubMed ID: 4434964
[No Abstract] [Full Text] [Related]
4. Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment.
Branch RA; Halliwell M; Jackson L; Roberts CJ
Br J Pharmacol; 1975 Oct; 55(2):263P. PubMed ID: 1201403
[No Abstract] [Full Text] [Related]
5. [Correlations of kinetics of antipyrine, indocyanine green and bromosulfophthalein in healthy subjects and in patients with cardiovascular diseases].
Adamska-Dyniewska H; Kowalczyk L
Pol Tyg Lek; 1978 Jul; 33(29):1143-5. PubMed ID: 704415
[No Abstract] [Full Text] [Related]
6. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
[No Abstract] [Full Text] [Related]
7. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
Birnie GG; Fitzsimons CP; Czarnecki D; Cooke A; Scobie G; Brodie MJ
Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
[TBL] [Abstract][Full Text] [Related]
9. [Changes in hepatic biotransformation in patients treated with beta-adrenergic drugs and prazosin].
Adamska-Dyniewska H; Dziekański S
Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):361-3. PubMed ID: 2626354
[TBL] [Abstract][Full Text] [Related]
10. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Shrewsbury RP
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
[TBL] [Abstract][Full Text] [Related]
11. Effects of physical stress on the disposition of drugs eliminated by the liver in man.
Swartz RD; Sidell FR; Cucinell SA
J Pharmacol Exp Ther; 1974 Jan; 188(1):1-7. PubMed ID: 4809269
[No Abstract] [Full Text] [Related]
12. [Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
Kuntz HD; Meessen D; May B
Med Welt; 1982 Jun; 33(25):909-10. PubMed ID: 7109938
[No Abstract] [Full Text] [Related]
13. [Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
Adamska-Dyniewska H
Pol Arch Med Wewn; 1978 Oct; 60(4):313-8. PubMed ID: 714726
[No Abstract] [Full Text] [Related]
14. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
Hayes PC; Bouchier IA
Am J Gastroenterol; 1989 Jul; 84(7):723-6. PubMed ID: 2741882
[TBL] [Abstract][Full Text] [Related]
15. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
Roberts CJ; Jackson L; Halliwell M; Branch RA
Br J Clin Pharmacol; 1976 Oct; 3(5):907-13. PubMed ID: 973986
[TBL] [Abstract][Full Text] [Related]
16. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
[TBL] [Abstract][Full Text] [Related]
17. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
18. Hepatic drug clearance in patients with mild cystic fibrosis.
Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
[TBL] [Abstract][Full Text] [Related]
19. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
Cousins MJ; Gourlay GK; Knights KM; Hall PD; Lunam CA; O'Brien P
Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
